Venom immunotherapy during COVID-19 pandemic: Experience from a University Allergy Center in Northern Italy

During the ongoing pandemic of Coronavirus Disease 2019 (COVID-19) allergic patients need to continue their constant and proper treatment, including allergen-specific immunotherapy. These patients are expected to be at a higher risk for exacerbation of lung inflammation during viral infection. We in...

Descripción completa

Detalles Bibliográficos
Autores principales: Dell’Edera, Alessandro, Borghesan, Franco, Favero, Elisabetta, Rattazzi, Marcello, Scarpa, Riccardo, Tartaglia, Leonardo, Agostini, Carlo, Cinetto, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: World Allergy Organization 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7664475/
https://www.ncbi.nlm.nih.gov/pubmed/33224428
http://dx.doi.org/10.1016/j.waojou.2020.100489

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7664475/
https://www.ncbi.nlm.nih.gov/pubmed/33224428
http://dx.doi.org/10.1016/j.waojou.2020.100489

Ejemplares similares